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ABSTRACT 
The loss of muscle mass and its strength is one of the most critical changes in aging which is associated with an 
increased risk of falls, osteoporotic fractures and mobility disability. Vitamin D, with its extra-skeletal benefits, 
might improve muscle function in elderly. The current systematic review and meta-analysis of randomized con-
trolled trials (RCTs) was conducted to summarize available relevant data and determine the effect of vitamin D 
supplementation on muscle function among postmenopausal women. We reached databases including; Cochrane 
library, Embase, PubMed, and Web of Science database until the end of May 2018 to identify relevant published 
RCTs. Heterogeneity among included studies was assessed using Q-test and I2 statistics. Random-effect model 
was applied to pool data and weighted mean difference (WMD) was calculated representing summary effect size. 
Outcomes of interest included the effects of vitamin D supplementation on hand grip strength (HGS), back muscle 
strength (BMS), and Timed Up and Go (TUG). Twelve RCTs out of 1739 potential reports were included in our 
meta-analysis. The pooled findings showed that vitamin D supplementation had no significant effect on HGS 
(WMD -0.03 kilogram (Kg); 95 % CI, -0.26, 0.20; P=0.78), BMS (WMD 7.21 newton (N); 95 % CI, -5.98, 20.40; 
P=0.28), and TUG (WMD 0.01 second (S); 95 % CI, -0.17, 0.18; P=0.93) in postmenopausal women. Overall, the 
current meta-analysis showed that taking vitamin D supplementation by postmenopausal women did not affect 
markers of muscle function. Further studies are required to confirm the effect of vitamin D supplementation on 
markers of muscle function.  
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INTRODUCTION 
Muscle function is one of the main deter-
minants of functional capacity among post-
menopausal women. Lack of muscle mass 
and muscle strength occurs as important or-
ganic changes by aging and is remarkably as-
sociated with an elevated risk of falls and sub-
sequent osteoporotic fractures, besides this 
severely influences the potential of movement 
(Orsatti et al., 2011; Muir and Montero-
Odasso, 2011). Vitamin D deficiency is com-
mon among older populations worldwide, as 
more than 60 % of postmenopausal women 
are vitamin D deficient, regardless of other 
nutrient deficiencies (Rizzoli et al, 2006; 
Holick, 2007; Han et al., 2018). In observa-
tional studies, optimal serum 25(OH)D levels 
have been significantly associated with im-
proved musculoskeletal function and muscle 
strength (Bischoff-Ferrari et al., 2004a; 
Visser et al., 2003). Further, postmenopausal 
women who were vitamin D deficient pre-
sented worse upper and lower limb muscle 
strength and physical performance compared 
to vitamin D sufficient control group (Io-
lascon et al., 2015). Skeletal muscle cells have 
vitamin D receptor and adequate protein syn-
thesis in these cells, which might be directed 
through vitamin D function (Holick, 2007).  
Current evidence evaluating the effects of 
vitamin D supplementation on musculoskele-
tal health has demonstrated promising results. 
In a meta-analysis conducted by Rosendahl-
Riise et al. (2017), vitamin D supplementation 
alone or its co-administration with calcium 
supplements significantly improved muscle 
strength among community-dwelling older 
individuals. In another meta-analysis, con-
suming vitamin D by healthy people signifi-
cantly increased upper and lower limb 
strength (Tomlinson et al., 2015). Moreover, 
Rejnmark (2011) reported the advantages of 
vitamin D supplementation on muscle 
strength and function in older adults. In an-
other trial, taking vitamin D by postmenopau-
sal women increased their muscle strength, 
controlled lean mass loss and protected them 
against the occurrence of sarcopenia (loss of 
skeletal muscle mass) (Cangussu et al.,, 
2015). One-year treatment with high-dose vit-
amin D did not show any significant effect on 
muscular strength, balance or quality of life in 
postmenopausal osteoporotic women (Grim-
nes et al., 2017).  
Despite existing published RCTs evaluat-
ing the effect of vitamin D on muscle func-
tion, current evidence is inconclusive because 
of lack of trials conducted among younger 
populations and discrepant findings in older 
individuals. Discrepancies in current findings 
might be due to the differences in study de-
sign, study populations’ characteristics, the 
dosage of vitamin D supplementation, the du-
ration of intervention, co-supplementation 
with other nutrients and chronic comorbid 
conditions among elderly. This meta-analysis 
was conducted to summarize available data 
and to determine the effect of vitamin D sup-
plementation on muscle function among post-
menopausal women. 
 
METHODS 
Search strategy and study selection  
Two independent authors systematically 
searched databases including PubMed, EM-
BASE, Scopus, Cochrane Library, and Web 
of Science databases to identify RCTs inves-
tigating the impact of vitamin D on muscle 
function outcomes. Included trials were re-
stricted to human clinical trials published in 
English until May 2018. The following MeSH 
and text terms were used to determine related 
studies, using their title and abstract: partici-
pants ["post menopause" OR "postmenopau-
sal" OR "PMP"], intervention ("ergocalcif-
erol" OR "alphacalcidol" OR "cholecalcif-
erol" OR "eldecalcitol" OR "alfacalcidol" OR 
"vitamin D" OR "vitamin D2" OR "vitamin 
D3" AND "intake" OR "supplementation"), 
and outcomes ["hand grip strength (HGS)" 
OR "back muscle strength (BMS)" OR 
"Timed Up and Go (TUG)"].  
To increase the possibility of including 
more related studies, the reference list of se-
lected studies and previously published rele-
vant reviews were manually searched.  
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Inclusion and exclusion criteria 
First, duplicate studies and those clearly 
were not relevant were removed from further 
investigation. Then, the full-texts of remain-
ing studies were retrieved to assess whether 
these trials met the inclusion criteria for the 
current meta-analysis. The inclusion criteria 
were as followed: being a human RCTs (ei-
ther parallel or cross-over method), study 
population were post-menopause women, be-
ing a placebo-controlled trial, mean differ-
ence and standard deviations (SDs), standard 
error of the mean (SEMs), or 95 % confidence 
intervals (CIs) were available for considered 
outcomes including HGS, BMS, and TUG at 
both baseline and end of the intervention for 
each group. Observational studies, case re-
ports, animal, and in vitro studies, and RCTs 
did not meet the minimum requirement for the 
assessment of methodological quality were 
excluded from this meta-analysis. 
 
Data extraction and quality assessment 
The quality of selected RCTs methodol-
ogy was assessed, using Cochrane Collabora-
tion risk of bias tool and the data were ex-
tracted, using standardized excel sheet, by 
two independent authors (JH and MA). The 
following items were used to assess the qual-
ity of selected clinical RCTs and the probable 
risk of bias: "randomization generation, allo-
cation concealment, blinding of participants 
and outcome assessment, incomplete out-
come data, and selective outcome reporting, 
and other sources of bias". The following data 
were extracted from each study: first author’s 
name, publication year, participants’ age, 
study design and location, sample size in 
treatment and placebo groups, dosage of in-
tervention, type of vitamin D supplement and 
placebo, and the mean (SD) changes for mus-
cle outcomes in each group. If muscle out-
comes were measured at multiple durations of 
intervention or using different dosages of vit-
amin D supplementation in selected studies, 
those measurements were considered as sepa-
rate trials in meta-analysis. Any discrepancy 
in data extraction was resolved with consen-
sus or by discussing with a third author (ZA). 
Data synthesis and statistical analysis 
Weighted mean differences (WMDs) 
were used to determine the impacts of vitamin 
D supplementation on muscle outcomes in-
cluding HGS, BMS, and TUG for each clini-
cal trial. The changed value approach was ap-
plied to estimate the pooled effect sizes for 
each outcome. Authors evaluated existing 
heterogeneity across included RCTs, using 
Cochrane’s Q test and I-square (I2). Heteroge-
neity was defined as the I2 more than 50 per-
cent with P <0.05. Upon existing heterogene-
ity, random-effect model was applied, using 
DerSimonian and Laird method; otherwise a 
fixed-effect model with inverse variance 
method was used to calculate the pooled 
WMDs with 95 % confidence interval (CI). 
Further, sensitivity and subgroup analyses 
were conducted to calculate the effects of 
each study on pooled WMDs and to examine 
the source of heterogeneity, using the possible 
moderator variables, respectively. P value < 
0.05 was considered as statistically significant 
level. Statistical analyses were performed us-
ing STATA software version 12.0 (Stata 
Corp., College Station, TX) and RevMan 
V.5.3 software (Cochrane Collaboration, Ox-
ford, UK).  
 
RESULTS 
Description of the selected RCTs  
Initially, literature search identified 1739 
potential studies. After screening based on 
keywords, removing duplicates and assessing 
the quality of identified papers, twelve arti-
cles (or 16 trials) were included in the meta-
analysis. The detailed flowchart of step-by-
step identification and selection of the RCTs 
following literature review has been illus-
trated in Figure 1. The main characteristics of 
selected RCTs have been summarized in Ta-
ble 1.  
Overall in 16 trials, 7765 subjects (3788 
individuals in intervention and 3977 in con-
trol groups) were included in the meta-analy-
sis. Eleven RCTs reported the effects of vita-
min D on HGS (kilogram (Kg)), three on 
BMS (newton (N)), and six on TUG (secon 
(S)). This meta-analysis included RCTs pub-
EXCLI Journal 2019;18:591-603 – ISSN 1611-2156 
Received: April 27, 2019, accepted: July 23, 2019, published: August 06, 2019 
 
 
594 
 
Figure 1: Flowchart of literature search for selection of trials 
 
 
lished from 2000 till 2018. Duration of inter-
vention and the dosages of vitamin D supple-
ment varied from 12 to 96 weeks and 10 to 
50,000 IU/day, respectively. 
 
Risk of bias and publication bias 
Egger and Begg’s statistics were used to 
assess the possibility of publication bias 
across included RCTs. Our findings indicated 
no significant evidence of publication bias for 
studies included in the meta-analyses evaluat-
ing the impact of vitamin D supplementation 
on HGS (P Egger’s test=0.48, P Begg’s test= 
0.58) and BMS (PEg=0.71, PBe= 0.60). We 
found publication bias for TUG (PEg=0.02, 
PBe= 0.18), therefore non-parametric method 
(Duval and Tweedie) was applied to examine 
the censored study findings. However, the re-
sults showed that overall pooled WMD for 
TUG did not significantly vary between pre 
(WMD 0.01 S; 95 % CI, -0.17, 0.18) and post 
(WMD 0.01 S; 95 % CI, -0.17, 0.18) includ-
ing censored RCTs., the methodological qual-
ity of the included RCTs was judged, follow-
ing Cochrane Handbook for Systematic Re-
views of Interventions, by authors and the 
findings for different items have been illus-
trated in Figure 2.
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Table 1: Characteristics of included studies 
Authors (Ref) Publica-tion year 
Sample size 
(control/ 
intervention)
Country/ 
population 
Intervention  
(name and daily dose) 
Treatment 
duration 
Dosage of 
vitamin D 
(IU/day)
Age (y)
 (control, 
intervention)
Presented 
data 
Wood(a) et al.  2014 100/97 United King-dom/PMP 400 IU vitamin D 48 weeks 400 60-70 HGS 
Wood(b) et al.  2014 100/96 United King-dom/PMP 1000 IU vitamin D 48 weeks 1000 60-70 HGS 
Janssen et al.  2010 34/36 Nether-lands/PMP 400 IU vitamin D+500 mg calcium 24 weeks 400 65 and older HGS, TUG 
Hansen(a) et 
al.  2015 73/74 Wisconsin/PMP 50,000 IU cholecalciferol 48 weeks 50000 
75 years or 
younger TUG 
Hansen(b) et 
al.  2015 73/73 Wisconsin/PMP 800 IU cholecalciferol 48 weeks 800 
75 years or 
younger TUG 
Saito et al.  2016 17/18 Japan/PMP 0.75 μg eldecalcitol+ alendronate at 35 mg/week 24 weeks 30 63–86 
HGS, BMS, 
TUG 
Zhu et al.  2010 132/129 Australia/PMP 1,000 IU vitamin D +calcium 48 weeks 1000 70-90 TUG 
Cangussu et 
al.  2015 80/80 Brazil/PMP 1,000 IU vitamin D 36 weeks 1000 50-65 HGS 
Gao(a) et al.  2015 262/107 China/PMP 800 IU vitamin D +600 mg calcium 96 weeks 800 63.44±5.04 HGS 
Gao(b) et al.  2015 262/116 China/PMP 0.25 μg calcitriol+ 600 mg calcium 96 weeks 10 63.44±5.04 HGS 
Anek et al. 2015 26/26 Thailand/PMP 20,000 IU/week vitamin D 4 weeks 2858 45-55 BMS 
Glendenning 
et al.  2012 333/353 Australia/PMP 
150,000 IU/every 3 months vitamin 
D 36 weeks 1667 77 HGS, TUG 
Brunner(a) et 
al.  2008 1265/1334 USA/PMP 
1,000 mg calcium carbonate plus 
400 IU vitamin D3 24 weeks 400 50-79 HGS 
Brunner(b) et 
al.  2008 1162/1185 USA/PMP 
1,000 mg calcium carbonate plus 
400 IU vitamin D3 96 weeks 400 50-79 HGS 
Cavalcante et 
al.  2015 14/14 Brazil/PMP 943 IU vitamin D3 12 weeks 943 62 HGS 
Hara et al.  2013 44/50 Japan/PMP 1.0 µg alfacalcidol+ 200 mg cal-cium+ alendronate 35 mg/weeks 24 weeks 40 55-75 BMS 
PMP, postmenopausal; HGS, hand grip strength; BMS, back muscle strength; TUG, Timed Up and Go 
Number of RCTs used different types of dosage or duration for estimating the relevant outcomes, these articles were showed with subscript letters (a, b). We treated with these 
as a separate trial to be included in the current meta-analysis. 
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Figure 2: The methodological quality of included trials (risk of bias)
EXCLI Journal 2019;18:591-603 – ISSN 1611-2156 
Received: April 27, 2019, accepted: July 23, 2019, published: August 06, 2019 
 
 
597 
Main outcomes, muscle function 
The pooled results of included RCTs indi-
cated that vitamin D supplementation did not 
affect any significant effect on HGS (WMD -
0.03 Kg; 95 % CI, -0.26, 0.20; P=0.78), BMS 
(WMD 7.21 N; 95 % CI, -5.98, 20.40; 
P=0.28), and TUG (WMD 0.01 S; 95 % CI, -
0.17, 0.18; P=0.93) in postmenopausal 
women (Table 2 and Figure 3A-C). 
 
Subgroups and sensitivity analyses 
The findings of subgroup analyses for the 
effect of vitamin D supplementation on mus-
cle outcomes have been summarized in Table 
3. 
Sensitivity analysis was applied to assess 
the impact of each study on the reliability of 
the association between vitamin D supple-
mentation and muscle function. After exclud-
ing each study from the analyses, we observed 
no considerable difference between the pre- 
and post-sensitivity pooled WMD for HGS, 
BMS, and TUG. However, the lower and up-
per pooled WMD for HGS in the sensitivity 
analysis were -0.09 Kg (95 % CI: -0.35, 0.17) 
after omitting Brunner(b) et al. (2008) and 0.05 
Kg (95 % CI: -0.20, 0.30) after omitting 
Glendenning et al. (2012), respectively. For 
BMS, the lower WMD in the sensitivity anal-
ysis was 5.15 N (95 % CI: -14.78, 25.10) after 
excluding Hara et al. (2013) and upper pooled 
WMD was 10.61 N (95 % CI: -5.42, 26.64) 
after excluding Anek et al. (2015). The lower 
WMD for TUG was -0.13 S (95 % CI: -0.41, 
0.14) after omitting Glendenning et al. (2012) 
and upper pooled WMD was 0.02 S (95 % CI: 
-0.15, 0.20) after omitting Zhu et al. (2010).  
 
 
Table 2: The effects of vitamin D supplementation on muscle strength in postmenopausal women  
Variables Number 
of study 
Weighted 
mean  
difference 
CI 95 % P-
value  
Heterogeneity 
I2 
(%) 
Q P- value 
heteroge-
neity 
HGS Placebo group  
(after vs. before) 
8 -0.67 -1.13, 
-0.21 
0.004 0.0 3.20 0.866 
Intervention 
group (after vs. 
before) 
8 -0.35 -0.94, 
0.25 
0.250 40.7 11.80 0.107 
Change inter-
vention group vs.  
placebo group 
11 -0.03 -0.26, 
0.20 
0.788 0.0 9.51 0.482 
BMS Placebo group  
(after vs. before) 
2 5.74 -12.50, 
23.9 
0.537 0.0 0.00 0.998 
Intervention 
group (after vs. 
before) 
2 11.80 -9.39, 
33.00 
0.275 0.0 0.69 0.405 
Change inter-
vention group vs.  
placebo group 
3 7.21 -5.98, 
20.40 
0.284 0.0 0.78 0.678 
TUG Placebo group  
(after vs. before) 
5 -0.43 -0.77, 
 -0.09 
0.012 0.0 3.74 0.443 
Intervention 
group (after vs. 
before) 
5 -1.00 -1.83, 
-0.17 
<0.001 76.1 16.74 0.002 
Change inter-
vention group vs.  
placebo group 
6 0.01 -0.17, 
0.18 
0.939 0.0 4.36 0.499 
HGS, hand grip strength; BMS, back muscle strength; TUG, Timed Up and Go 
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Table 3: The association between vitamin D supplementation on muscle strength in postmenopausal 
women based on subgroup analysis  
Variables Number 
of trials 
Subgroups Pooled 
WMD 
95 % CI I2 
(%) 
P* over-
all 
I2 (%) 
HGS  Dosage of vita-
min D (IU/day) 
8 <1000 0.11 -0.16, 
0.37 
0.0 0.05 0.0 
 3 ≥1000 -0.41 -0.85, 
0.04 
0.0 
Duration of study 
(week) 
 
5 >40 weeks -0.00 -0.33, 
0.33 
29.9 0.80 
6 ≤40 weeks -0.06 -0.38, 
0.26 
0.0 
Treatment type 5 Vitamin D -0.31 -0.69, 
0.08 
0.0 0.08 
6 Vitamin D plus 
other nutrients 
 
0.12 -0.17, 
0.40 
0.0 
BMS Dosage of vita-
min D (IU/day) 
2 <1000 10.61 -5.43, 
26.65 
0.0 0.46 0.0 
 1 ≥1000 0.10 -23.08, 
23.2 
- 
Duration of study 
(week) 
 
- >40 weeks - - - - 
3 ≤40 weeks 7.21 -5.98, 
20.40 
0.0 
Treatment type 1 Vitamin D 0.10 -23.08, 
23.2 
- 0.46 
2 Vitamin D plus 
other nutrients 
 
10.61 -5.43, 
26.65 
 
0.0 
TUG Dosage of vita-
min D (IU/day) 
3 <1000 -0.14 -0.52, 
0.24 
0.0 0.39 0.0 
 3 ≥1000 0.05 -0.15, 
0.25 
37.0 
Duration of study 
(week) 
 
3 >40 weeks -0.11 -0.40, 
0.18 
11.2 0.31 
3 ≤40 weeks 0.07 -0.15, 
0.29 
0.0 
Treatment type 3 Vitamin D 0.04 -0.14, 
0.22 
0.0 0.08 
 3 Vitamin D plus 
other nutrients 
 
-0.67 -1.47, 
0.13 
0.0  
HGS, hand grip strength; BMS, back muscle strength; TUG, Timed Up and Go 
*Overall test for heterogeneity between sub-groups 
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Figure 3A-C: Meta-analysis on muscle outcomes weighted mean differences estimates for (A) HGS, 
(B) for BMS, and (C) for TUG in vitamin D and placebo groups (CI=95 %) 
 
 
 
DISCUSSION 
To our best knowledge, this systematic re-
view and meta-analysis was the first report 
determining the effect of vitamin D supple-
mentation on muscle function among post-
menopausal women. This meta-analysis 
showed that taking vitamin D supplementa-
tion by postmenopausal women did not affect 
markers of muscle function.  
Current evidence demonstrating the im-
pact of vitamin D supplementation on lower 
extremity muscle strength and function are 
controversial. While some trials have con-
firmed a significant effect of vitamin D ad-
ministration on improving lower extremity 
muscle strength and function in older popula-
tion (Gloth et al., 1995; Verhaar et al., 2000), 
others did not (Kenny et al., 2003; Latham et 
al, 2003). Most of these studies included 
males and females who were not vitamin D 
deficient. In a study conducted by Zhu et al. 
(2010), 1,000 IU/day vitamin D supplementa-
tion for 1 year significantly improved muscle 
strength in subjects who had low baseline 
muscle strength and whose serum 25(OH)D 
levels were below 24 ng/mL. TUG represents 
basic mobility skills, it is an effective method 
and evaluates functional mobility in older 
population (Podsiadlo and Richardson, 1991). 
It is also a sensitive and specific measure for 
identifying the risk of fall among community-
dwelling adults older than 65 years (Shum-
way-Cook et al., 2000). Further, vitamin D in-
gestion was shown to improve neuromuscular 
coordination in older adults who had a history 
of fall with serum 25(OH)D levels less than 
30 nmol/L (12 ng/mL) (Dhesi et al., 2004). 
So, TUG improvement could be correlated 
with improved muscle strength and neuro-
3C 
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muscular function. In a meta-analysis con-
ducted by Beaudart et al. (2014), vitamin D 
supplementation had a modest positive im-
pact on muscle strength. In another meta-
analysis, vitamin D supplementation to 
healthy individuals increased upper and lower 
limb strength (Tomlinson et al., 2015). On the 
other hand, Rosendahl-Riise et al. (2017 did 
not observe any improvement in muscle 
strength following vitamin D supplementa-
tion (with or without calcium supplements) in 
community-dwelling older population in their 
meta-analysis. Epidemiological studies have 
proposed serum 25(OH)D levels greater than 
20 ng/mL as a desirable level for optimal 
lower extremity strength (Wicherts et al., 
2007; Bischoff-Ferrari et al., 2004b). The 
dosages of vitamin D used, type of vitamin D 
and the duration of intervention are some pos-
sible reasons which might explain the incon-
clusive results regarding the impacts of vita-
min D on muscle function. 
Low circulating levels of vitamin D is 
usually asymptomatic, however patient may 
present with loss of muscle mass and muscle 
weakness (Bergman et al., 2010). Muscle 
cells have vitamin D receptors (VDR) (Bis-
choff-Ferrari et al., 2009). Vitamin D metab-
olites can influence muscle cell metabolism 
through activating gene transcription, varia-
tion in the VDR allele, and rapid pathways not 
involved in DNA synthesis (Bischoff-Ferrari 
et al., 2009; Barr et al., 2010). Supplementa-
tion with vitamin D might enhance appendic-
ular muscle strength and increase physical 
function, particularly in vitamin D deficient 
older population (Bischoff et al., 2003; Pfeifer 
et al., 2009). 
The current study had a few limitations. 
We found a significant heterogeneity across 
included trials which might be explained 
through the large number of studies included 
and the variability observed between different 
protocols of supplementation. However, we 
considered this heterogeneity by applying a 
random effect model in meta-analyses. We 
were also unable to find any dose-response ef-
fect in this meta-analysis, which is probably 
due to the variability of the different supple-
mentation protocols across included studies.  
 
CONCLUSIONS 
Overall, the current meta-analysis showed 
that taking vitamin D supplementation by 
postmenopausal women did not affect mark-
ers of muscle function. Further studies are re-
quired to confirm the effect of vitamin D sup-
plementation on markers of muscle function.  
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